Roivant Sciences (ROIV): High-Growth UK Stock with Innovative Drug Development Model

By Yahoo! Finance | Oct 17, 2024 at 02:45 PM EST

Roivant Sciences (NASDAQ:ROIV) is a UK high-growth stock, known for its innovative biopharmaceutical developments. The company recently made a strategic sale of its subsidiary to Organon & Co., boosting its market presence. Analysts predict a 35.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.